Research on doxyPEP to prevent sexually transmitted infections, antimicrobial resistance & microbiome. Led by Dr Manik Kohli @UCL_CRISH. Funders NIHR/BHIVA/BIA.
United Kingdom
Joined February 2024
- Tweets5
- Following91
- Followers9
- Likes0
SPEAR retweeted
Out today - We looked at doxyPEP uptake among >11,000 PrEP users at Kaiser Permanente Northern California.. 1 in 5 started #doxyPEP within a year of availability, and STI incidence declined following uptake. Prescribing DoxyPEP outside of clinical trials reduces STIs.
Receipt of doxyPEP was associated with substantial declines in chlamydia and syphilis incidence and modest declines in urethral and rectal gonorrhea incidence among individuals using HIV PrEP. ja.ma/41VQmVQ
We are open for recruitment! The
@SPEARstudy is investigating antibiotic resistance and microbiome changes in people using and not using doxyPEP to prevent STIs. Visit doxypep.me/spear
We are open for recruitment! The @SPEARstudy is investigating antibiotic resistance and microbiome changes in people using and not using doxyPEP to prevent STIs. More details below doxypep.me/spear
